Midazolam is a popular sedative in paediatric practice. There are numerous reports of its value as premedication in children following oral 1 , rectal 2 or transmucosal 3 administration. It is also being used increasingly with satisfactory effects to provide sedation in children undergoing various minor invasive procedures 4, 5 . The usual responses to midazolam include lessening of anxiety, improved co-operation and sedation. However, in common with other benzodiazepines, midazolam may occasionally produce a paradoxical reaction in some adults and children with aggression, excitement and behavioural disturbance which may be difficult to manage [6] [7] [8] [9] . We report a case of a paradoxical reaction in a child following the oral administration of midazolam which was treated successfully with intravenous flumazenil.
CASE REPORT
An eleven-year-old boy with a three-month history of nephrotic syndrome was admitted to hospital because of clinical relapse. Due to two previous episodes of relapse he required high doses of prednisolone, and at the time of admission he had been taking 75 mg prednisolone daily for 10 days. On admission he had obvious signs of nephrosis and his body weight had increased from his normal 34.5 kg to 37.5 kg.
Laboratory investigations were as follows: sodium 138 mmol/l, potassium 3.7 mmol/l, urea 3.3 mmol/l, total protein 42 g/l, and albumin 21g/l.
It was necessary to establish intravenous access, but because of a previous skin reaction, local anaesthetic cream could not be applied. Therefore, in order to avoid any distress during the procedure, 17.5 mg of midazolam was given orally. When he became drowsy a vein was cannulated uneventfully. Forty minutes after taking the oral midazolam his behaviour changed abruptly. He started to scream and kick and was confused and uncontrollable.
There was no evidence of airway obstruction or hypoxia. Pulse oximetry showed oxygen saturation of 100%. He required gentle physical restraint to avoid self-injury. Prior to this incident his demeanour had always been docile and quiet. The behavioural change was marked and extremely distressing for family and staff. He was well known to one of the authors (P.T.) who considered this behaviour to be totally out of character. Reassurance and supportive care had no effect and in view of his bizarre behaviour a diagnosis of paradoxical reaction to midazolam was considered. Flumazenil 0.15 mg was then given intravenously in an attempt to reverse the symptoms. Within one minute his agitation ceased and he assumed his normal behaviour. For several hours following this event he had ECG and oxygen saturation monitoring and all observations were stable. He remained rational, alert and cheerful and there was no recurrence of his earlier behavioural disturbance. On later questioning of the child he had no memory of the event.
DISCUSSION
Paradoxical reactions to benzodiazepines have been well documented but it may be difficult to establish the diagnosis in the individual case 10 . It has been suggested that a paradoxical response may be idiosyncratic and that it is not possible to predict which patient is at risk 10 , but others have suggested that it may be associated with underlying personality disorders 11 or may be genetically determined 12 . The clinical events may be confounded by the concomitant administration of other mood altering drugs 8 or by general anaesthesia 13 . Hypoventilation with hypoxia and hypotension may occur with systemic administration of benzodiazepines and may be also associated with confusion. Moreover children may react normally to a stressful or frightening situation with aggressive behaviour and screaming. None of these factors were relevant in this case.
This patient was taking prednisolone, which may induce psychosis and abnormal behaviour. However his behaviour had been entirely normal and appropriate until he received oral midazolam. There was no evidence of cardiorespiratory depression. In addition he was well known to experienced nurses and doctors during this and three earlier admissions and he had never displayed aggressive behaviour previously. His behaviour remained normal following the administration of flumazenil and there has not been any recurrence during subsequent re-admissions to the hospital. Therefore we are confident that this case represents a true case of a paradoxical reaction to midazolam.
Since flumazenil has been used successfully in reversing midazolam-related sedation in children 14 , it seemed reasonable to consider that it might also reverse the paradoxical effects. In this case intravenous flumazenil completely abolished the child's symptoms, with almost immediate restoration of normal behaviour. To our knowledge this is the first report of the use of flumazenil in a child in the context of a paradoxical reaction, though it has previously been used in adults for this purpose [15] [16] [17] . In reports of the use of flumazenil for reversing midazolam-induced sedation and anaesthesia in children, the recommended dose of flumazenil ranged from 0.005 mg/kg to 0.1 mg/kg 18 . It seemed prudent to start treatment with the lower dose range and to titrate against the response. In this case approximately 0.005 mg/kg was adequate for reversal of the paradoxical response. Although flumazenil was administered intravenously it may also be given rectally 19 , which may be an appropriate route in children if intravenous access is difficult. In common with others' experience with flumazenil in children and adults, we found that it reversed the paradoxical effects of midazolam but the anxiolytic effect was retained 14, 16, 17 .
The mechanism of paradoxical reactions to benzodiazepines is complex. Benzodiazepines act centrally at the benzodiazepine receptor site which is part of the gamma-amino-butyric acid (GABA) receptor complex 20 . They increase the effect of GABA, the principal inhibitory neurotransmitter in the central nervous system. They may also affect the action of other neurotransmitters acetylcholine, 5 hydroxytryptamine and cathecholamines 10 . The clinical response to benzodiazepines depends not only on the number of receptor sites occupied but on the multiplicity of factors including the patient's individual response to stressful events 20 . The incidence of paradoxical reactions to midazolam appears to be low, but they have been in observed in children following oral, rectal and intranasal administration 9 .
It has been suggested that paradoxical or dysphoric responses to midazolam are more likely in children if the oral dose exceeds 0.5 mg/kg 21 . In this patient, 17.5 mg of oral midazolam was considered appropriate for his corrected weight. However, midazolam is highly protein bound and in hypoalbuminaemia states, as in this patient, the pharmacokinetic profile of the drug may be altered 22 . Hypoalbuminaemia causes an increase in volume of distribution, decreased elimination half-life with increase in the level of unbound midazolam 23 . It may be that an inappropriately high level of free midazolam accounted for this patient's response. It has been suggested that a similar mechanism may account, in part, for an encephalopathy observed in children receiving infusions of midazolam in intensive care 24 .
Although it might seem unnecessary to sedate a child prior to siting an intravenous line, it is generally acknowledged that it is important to avoid distress in a child, particularly if frequent hospital admissions and invasive procedures are anticipated. The use of a topical local anaesthetic cream usually suffices, but this option was not available in this patient.
In the past, management of paradoxical reactions included supportive care, morphine 8 and physostigmine 25 and other sedatives 6, 7 . Flumazenil, a specific benzodiazepine antagonist, seems to be a more appropriate therapy. The response to flumazenil is prompt which is particularly advantageous if the reaction occurs during sedation for a surgical procedure 16, 17 . Flumazenil has been used successfully in various clinical situations but most commonly in reversing benzodiazepine-related sedation or overdose 18 . Because of its short duration of action, there is a risk of recurrence of the original benzodiazepine effects. For this case one dose of flumazenil was sufficient to reverse the paradoxical reaction, without further recurrence of symptoms.
Although flumazenil is generally well tolerated there are reports of dysrhythmias 26 and seizures 27 following its administration to adults who have taken an overdose of various sedatives and antidepressants. Although there are no similar reports in children, it is recommended that it should be used with caution in patients whose epilepsy is controlled by benzodiazepines, and in cases of mixed drug overdose 18 .
Midazolam has many of the features of the ideal premedicant or sedative in children 28 and it is not our intention to detract from its role in paediatrics. We wish to highlight the fact that occasionally it may provoke the unpleasant symptoms of a paradoxical response. In this case the paradoxical effects may have been related to higher than anticipated levels of free midazolam. Thus we would suggest that midazolam should be used with caution in children with hypoalbuminaemia.
The recommended oral dose of midazolam in children requires further evaluation. The metabolic turnover of midazolam is more rapid in children than in adults 29 . Children require 0.5 mg/kg of midazolam orally for optimum effect 28 , whereas in healthy adults a single oral dose of 15 mg is usually sufficient 30 . The requirements for children are based on studies in children less than 10 years old and weighing less than 30 kg 21, 29 . This regimen may be inappropriate in older children and adolescents whose metabolic profile is more mature and may produce toxicity. Although it is not possible to define with certainty when the dose of 0.5 mg/kg is no longer valid, it would seem reasonable to set an arbitrary limit of 15 mg to the oral dose of midazolam in children.
Paradoxical reactions to midazolam are distressing for the child, family and carers. It is reassuring that these effects can now be readily reversed with flumazenil. We would recommend that flumazenil should be available wherever midazolam is administrated to facilitate management of any of its side-effects.
